Life’s Essential 8: key to reducing heart disease and mortality through epigenetics

MRM Health’s mi­cro­bio­me con­sor­tium ther­a­py for ul­cer­a­tive col­i­tis has shown promise in a Phase IIa tri­al, trig­ger­ing plans for late-stage de­vel­op­ment and po­ten­tial part­ner­ships. The Bel­gian

An electromagnetic therapy for depression shouldn’t damage a person’s pre-existing implantable cardioverter-defibrillator (ICD), multiple experiments indicated. There was a low risk of ICD damage or